✦ LIBER ✦

A pharmaco-economic evaluation of deferasirox for treating patients with iron overload caused by transfusion-dependent thalassemia in Taiwan

✍ Scribed by Ho, Wan-Ling; Chung, Kuo-Piao; Yang, Szu-Sheng; Lu, Meng-Yao; Jou, Shiann-Tarng; Chang, Hsiu-Hao; Yang, Yung-Li; Lin, Dong-Tsamn; Lin, Kai-Hsin

Book ID: 120070187
Publisher: Chinese Electronic Periodical Services
Year: 2013
Tongue: English
Weight: 204 KB
Volume: 112
Category: Article
ISSN: 0929-6646
DOI: 10.1016/j.jfma.2011.08.020

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Deferasirox: A Review of Its Use for Chr

Deferasirox: A Review of Its Use for Chronic Iron Overload in Patients with Non-Transfusion-Dependent Thalassaemia

✍ Shirley, Matt; Plosker, Greg L. 📂 Article 📅 2014 🏛 Springer International Publishing AG 🌐 English ⚖ 441 KB

A Time-Cost Augmented Economic Evaluatio

A Time-Cost Augmented Economic Evaluation of Oral Deferasirox versus Infusional Dereroxmine for Patients with Iron Overload in South Korea

✍ Jinhyun Kim; Younhee Kim 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

Results from a 1-year, open-label, singl

Results from a 1-year, open-label, single arm, multi-center trial evaluating the efficacy and safety of oral Deferasirox in patients diagnosed with low and int-1 risk myelodysplastic syndrome (MDS) and transfusion-dependent iron overload

✍ Nolte, F.; HÃ¶chsmann, B.; Giagounidis, A.; LÃ¼bbert, M.; Platzbecker, U.; Haase 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 215 KB